Hernandez, H.H. , Peterson, D.W., Chaikoff , I.L., AND Dauben, W.G.: Absorption of cholesterol-4-C14 in rats fed mixed soybean sterols and beta-sitosterol . Proc. Soc. Exper. Biol. & Med., 83: 498, 1953.
2.
Best, M.M., AND Duncan, C.H.: Modification of abnormal serum lipid patterns in atherosclerosis by administration of sitosterol. Ann. Int. Med., 45: 614, 1956.
3.
Shipley, R.E. , Pfeiffer, R.R., Marsh , M.M., AND Anderson , R.C.: Sitosterol feeding: chronic animal and clinical toxicology and tissue analysis. Circulation Res., 6: 373, 1958.
4.
Levere, A.H. , Bozian, R.C., Craft , G., Jackson, R.S., AND Wilkinson , C.F., JR.: The sitosterols: variability of serum cholesterol levels and difficulty of evaluating decholesterolizing agents. Metabolism, 7: 338, 1958.
5.
Berkowitz, D. , Likoff, W., AND Sklaroff, D.M.: The effect of sitosterol on radioactive fat absorption patterns. Am. J. Car-diol., 4: 282, 1959.
6.
Beveridge, J.M.R. , Connell, W.F., Mayer , G.A., AND Haust, H.L.: Plant sterols, degree of unsaturation, and hypocholesterolemic action of certain fats. Canad. J. Biochem. & Physiol., 36: 895, 1958.
7.
Altschul, R. : Influence of nicotinic acid on blood cholesterol and experimental atherosclerosis. Ztschr. Kreislaufforsch , 45: 573, 1956.
8.
Parsons, W.B. , JR., Achor, R.W.P., Berge, K.G., Mckenzie, B.F., AND Barker, N.W.: Changes in concentration of blood lipids following administration of large doses of nicotinic acid to persons with hypercholesterolemia: preliminary observations. Proc. Staff Meet. Mayo Clinic, 31: 391, 1956.
9.
Parsons, W.B. , AND Flinn, J.H.: Success of niacin and failure of niacinamide in reducing plasma cholesterol levels in patients with hypercholesterolemia . Circulation, 16: 923, 1957.
10.
Merrill, J.M. : Alteration of cholesterol synthesis with nicotinic acid. Clin. Res., 6: 141, 1958.
11.
Kritchevsky, D., Whitehouse, M.W., AND Staple E.: Influence of nicotinic acid on cholesterol oxidation by rat liver mitochondria. Clin. Res., 8: 26, 1960.
12.
Perry, W.F. : Effect of nicotinic acid and nicotinamide on incorporation of acetate into cholesterol, fatty acids and CO2 rat liver slices . Metabolism, 9: 686, 1960.
13.
Schade, H., AND Saltman, P.: Influence of nicotinic acid on hepatic cholesterol synthesis in rabbits . Proc. Soc. Exper. Biol. & Med., 102: 265, 1959 .
14.
Duncan, C.H. , AND Best, C.H.: Lack of nicotinic acid effect on cholesterol metabolism of the rat. J. Lip. Res., 1: 154, 1960.
15.
Friedman, M. , AND Byers, S.O.: Evaluation of nicotinic acid as an hypocholesterolemic and anti-atherogenic substance. J. Clin. Invest., 38: 1328, 1959.
16.
Parsons, W.B. , AND Flinn, J.H.: Reduction of serum cholesterol levels and beta-lipoprotein cholesterol levels by nicotinic acid. A.M.A. Arch. Int. Med., 103: 783, 1959.
17.
Roels, O., AND Merrill, J.M.: The effect of nicotinic acid on human serum linoleic acid concentration measured by alkaline isomerization and gas-liquid chromatography. Clin. Res., 8: 85, 1960.
18.
Parsons, W.B. , JR.: Reduction in serum cholesterol levels and other metabolic effects of large doses of nicotinic acid. Circulation, 20: 747, 1959.
19.
Berge, K.G., Achor, R.W.P., Christen-Sen, N.G., Power, M.H., AND Barker, N.W.: Hypercholesterolemia and nicotinic acid: long term study. Circulation, 20: 671, 1959.
20.
Rivin, A.U.: Jaundice occurring during nicotinic acid therapy for hypercholesterolemia . J. A. M. A., 170: 2088, 1959.
21.
Parsons, W.B. , JR.: Activation of peptic ulcer by nicotinic acid; report of five cases. J. A. M. A., 173: 1466, 1960 .
22.
Rinehart, J.F. , AND Greenberg, L.D.: Arteriosclerotic lesions in pyridoxine-deficient monkeys. Am. J. Path., 25: 481, 1949.
23.
Rinehart, J.F. , AND Greenberg, L.D.: Pathogenesis of experimental arteriosclerosis in pyridoxine deficiency with notes on similarities to human arteriosclerosis . A.M.A. Arch. Path., 51: 12, 1951.
24.
Schroeder, H.A.: Is atherosclerosis a conditioned pyridoxal deficiency?J. Chron. Dis., 2: 28, 1955.
25.
Swartwout, J.R., Unglaub, W.G., AND Smith, R.C.: Vitamin B6, serum lipids and placental arteriolar lesions in human pregnancy. Am. J. Clin. Nutrition , 8: 434, 1960.
26.
Failey, R.B. , JR.: Effect in man of large doses of pyridoxine in serum cholesterol. Circ. Res., 6: 203, 1958.
27.
Lukomsky, P.E. : The use of methionine, pyridoxine and unsaturated fatty acids in coronary atherosclerosis. Sovet. Med., 23: 14, 1959.
28.
Abitol, L., et al.: Linoleic acid and pyridoxine in hypercholesterolemia. Rev. brasil. med., 17: 322, 1960.
29.
Goldner, M.G. , Vallan, L.E.: Marked and sustained blood cholesterol lowering effect by medication with niacin and pyridoxine. Am. J. M. Sc., 236: 341, 1958.
30.
Paul, S., AND Steiner, A.: Reduction of the level of serum cholesterol in man by neomycin. Circulation, 18: 494, 1958.
31.
Steiner, A. , Finkel, M., AND Bakke, J.: Reduction of serum cholesterol level in patients with coronary atherosclerosis by oral neomycin. Circulation , 20: 774, 1959.
32.
Kowalfwski, K.: Serum and liver lipids in rats treated with neomycin. Proc. Soc. Exper. Biol. Med., 102: 448, 1959 .
33.
Broitman, S.A. , Kinnear, D.G., Gottlieb , L.S., Bezman, A.L., Vitale, J.J., AND Zamchek, N.: The effect of neomycin alteration of the rat intestinal flora on serum cholesterol and valvular sudanophilia. J. Lab. & Clin. Med., 55: 55, 1960.
34.
Fisher, E.R. : Effect of neomycin on cholesterol atherosclerosis in the rabbit. Proc. Soc. Exper. Biol. & Med., 103: 857, 1960.
35.
Goldsmith, G.A., Hamilton, J.G., AND Miller, O.N.: Mechanisms used by unsaturated fats, nicotinic acid and neomycin: excretion of sterols and bile acids— lowering of serum lipid concentrations. A.M.A. Arch. Int. Med., 105: 512, 1960.
36.
Paul, S.: On the mechanism of the reduction of serum cholesterol concentrations by neomycin in man. Circulation, in press.
37.
Cooper, E.: Inhibition of cholesterol biosynthesis in man. Circulation , 20: 681, 1959.
38.
Sachs, B.A. , Danielson, E., AND Sperber, R.: Hypocholesterolemic effects of N-(1. methyl -2-3-di-p- chlorophrenylpropyl)-maleamic acid in hyperlipemic and normolipemic man. Circulation, 20: 762, 1959.
39.
Furman, R.H. , Howard, R.P., Norcia , L.N., AND Robinson , C.W., JR.: The effect of benzmalacene on serum lipids and lipoproteins. J. Lab. & Clin. Med., 54: 817, 1959.
40.
Bergen, S.S. , JR., Van Itallie , T.B., AND Sebrell, W.H.: Hypocholesterolemic effect in man of benzmalacene; an inhibitor of cholesterol biosynthesis. Proc. Soc. Exper. Biol. & Med., 103: 39, 1960.
Bollinger, R.E., Grady, H.J., AND Slinker, B.J.: Effects of injected heparin on the electrophoresis of the lipoproteins in patients with hypercholesterolemia. Am. J. M. Sc., 227: 193, 1954 .
43.
Kuo, P.T., Joyner, C.R., AND Reinhold, J.G.: Effects of fat ingestion and heparin administration on serum lipids of "normal," hypercholesterolemic, hyperlipemic and atherosclerotic subjects . Am. J. M. Sc., 232: 613, 1956.
44.
Engelberg, H.: Short term studies of effect of heparin upon cholesterol excretion in man. Proc. Soc. Exper. & Biol. Med., 102: 365, 1959.
45.
Fuller, H.L. : Effect of sublingual heparin on recurrence of myocardial infarction. Circulation20: 699, 1959.
46.
Constantinides, P., Cairns, A., AND Werner, A.: Antilipemic activity of sulfated polysaccharides . Arch. internat. pharmacodyn ., 99: 334, 1954.
47.
Eilert, M.L. : Effect of estrogens on the partition of serum lipids in female patients. Metabolism, 2: 137, 1953.
48.
Barr, D.P., Russ, E.M., AND Eder, H.A.: Influence of estrogens on lipoproteins in atherosclerosis. Tr. A. Am. Physicians, 65: 102, 1952.
49.
Barr, D.P.: Some chemical factors in the pathogenesis of atherosclerosis. Circulation, 8: 641, 1953.
50.
Steiner, A. , Payson, H., AND Kendall, F.E.: Effect of estrogenic hormone on serum lipids in patients with coronary arteriosclerosis . Circulation, 11: 784, 1955.
51.
Stawler, J. , Pick, R., AND Katz, L.N.: Experimental and clinical studies on atherosclerosis: diabetes and insulin in chicks; estrogens in men with myocardial infarction . J. Lab. & Clin. Med. , 44: 933, 1954.
52.
Oliver, M.F. , AND Boyd, G.S.: The influence of sex hormones on the circulating lipids and lipoproteins in coronary sclerosis. Circulation , 13: 82, 1956.
53.
Marmorston, J., Moore, F.J., Lewis , J.J., Magidson, O., AND Kuzma, O.: Estrogen therapy in men with myocardial infarction: occurrence of lipid changes before feminization . Clin. Pharmacol. and Ther., 1: 449, 1960.
54.
Marmorston, J., Moore, F.J., Kuzma , O.T., Magidson, O., AND Weiner, J.: Survival benefit of estrogen in men with myocardial infarction. Clin. Res. , 9: 62, 1961.
55.
Furman, R.H. , Howard, R.P., AND Norcia, L.N.: Gonadal and adrenal steroid-induced changes in the cholesterol and phospholipid content of serum lipoprotein fractions isolated by simultaneous centrifugation at four solvent densities followed by quick freezing and tube-sawing. J. Lab. & Clin. Med. , 50: 816, 1957.
56.
Berezin, D., AND Von Studnitz, W. : The effect of the administration of sex hormones on serum lipids and lipoproteins in women. Acta endocrinol ., 25: 427, 435, 1957.
57.
Hood, B., AND Cramer, K.: Effects on serum lipoprotein cholesterol of estrogen in combination with Δ4-androstenedione, testosterone and methyl testosterone. Acta med. scandinav. , 165: 459, 1959.
58.
Blohm, T.R. , AND Mackenzie, R.D.: Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER/29). Arch. Biochem. , 85: 245, 1959.
59.
Blohm, T.R. , Kariya, T., AND Laughlin, M.W.: Effects of MER/29, a cholesterol synthesis inhibitor, on mammalian tissue lipids. Arch. Biochem., 85: 250, 1959.
60.
Gould, R.G. : Effects of MER/29 on sterol concentration in rat tissues and on cholesterol biosynthesis in vivo and in vitro from mevalonic acid-2-C14. Prog. Cardio. Dis., 2: 492, 1960.
61.
Frantz, I.D. , JR., Mobberly, M.L., AND Schroepfer , G.J., JR.: Effects of MER/29 on the intermediary metabolism of cholesterol. Prog. Cardiov. Dis., 2: 511, 1960.
62.
Avigan, J., Steinberg, D., Thompson, M.J., AND Mosettig, E.: The mechanism of MER/29. Prog. Cardiov. Dis., 2: 525, 1960.
63.
Hollander, W., AND Chobanian, A.: Effects of an inhibitor of cholesterol biosynthesis, triparanol (MER/29), in subjects with and without coronary artery disease . Boston Med. Quart., 10: 37, 1959.
64.
Oaks, W., Lisan, P., AND Myoer, J.M.: Inhibition of cholesterol synthesis with the use of MER/29. A. M. A. Arch. Int. Med., 104: 527, 1959.
65.
Steinberg, D., Avigan, J., AND Feigelson, E.B.: Identification of 24-dehydrocholesterol in the serum of patients treated with MER/29. Prog. Cardiov. Dis., 2: 586, 1960.
66.
Toro, J.: Evaluation of the administration of MER/29 to a group of institutionalized patients at the St. Louis Chronic Hospital; a preliminary report. Prog. Cardiov. Dis., 2: 544, 1960.
67.
Leckert, J.T. , Mchardy, G.G., McHardy , R.J., Welch, G.E., AND Cradic, H.: Clinical evaluation of MER/29 in the treatment of hypercholesterolemia associated with atherosclerosis . Prog. Cardiov. Dis., 2: 571 , 1960.
68.
Achor, R.W.P. , Winkelman, R.K., AND Perry, H.O.: Cutaneous side effects from the use of MER/29; preliminary data on Ichthyosis and loss of hair. Proc. Staff Meet. Mayo Clinic, 36: 217, 1961.
69.
Melby, J.C. , St. Cyr, M., And Dale, S.L.: Alterations in steroid hormone secretion produced by inhibition of cholesterol synthesis . J. Clin. Invest., 40: 1063, 1961.
70.
Blankenhorn, D.H., Maronde, R.F., AND Scholtz, J.R.: Occurrence and distribution of desmosterol in human arteries following treatment with MER/29. Circulation , in press.
71.
Spain, D.M. : The local tissue reaction in rabbits to gelfoam implants containing desmosterol or cholesterol. Proc. Soc. Exper. Biol. & Med., 106: 452, 1961.
72.
Srere, P.A. , Chaikoff, I.L., AND Dauben, W.G.: The in vitro synthesis of cholesterol from acetate by surviving adrenal cortical tissue . J. Biol. Chem. , 176: 829, 1948.
73.
Conn, J.W., Vogel, W.C., Louis, L.H., AND Fajans, S.S.: Serum cholesterol: A probable precursor of adrenal cortical hormones . J. Lab. & Clin. Med., 35: 504, 1950.
74.
Hechter, O.: Conversion of cholesterol to steroid hormones. In Cholesterol: Chemistry, Biochemistry and Pathology, edited by R. P. Cook, Ch. 8, p. 309. Academic Press, Inc., New York, 1958.
75.
Danowski, T.S. , AND Moses, C.: Hydrocortisone correction of physiologic hypercholesterolemia. Circulation, in press.
76.
Moses, C., Danowski, T.S., AND Switkes, H.I.: Alterations in cholesterol and lipoprotein partition in euthyroid by replacement doses of desiccated thyroid. Circulation, 18: 761, 1958.
77.
Turner, K.B. , AND Present, C.H.: The role of thyroid in the regulation of the blood cholesterol of rabbits. J. Exper. Med., 67: 111, 1938.
78.
Priddle, W.W. : Hypercholesterolemia; an analysis of 529 cases and treatment of 297 by a low animal fat diet and desiccated thyroid substance . Ann. Int. Med., 35: 836, 1951.
79.
Soffer, A., Yu, P.N.G., Epstein, M.A., AND Olson, E.S.: Serum lipid studies in euthyroid subjects following the administration of thyroid. Am. J. M. Sc., 222: 427, 1951.
80.
Starr, P.: Thyroxine therapy in preventive geriatrics. J. Am. Geriatrics Soc., 3: 217, 1955.
81.
Strisower, B., Gofman, J.W., Galioni , E.F., Aubinger, J.M., Pouteau, J., AND Guzvich, P.: Long-term effect of dried thyroid on serum lipoprotein and serum cholesterol levels. Lancet, 272: 120, 1957.
82.
Byers, S.O. , Rosenman, R.H., Friedman , M., AND Biggs, M.W.: Rate of cholesterol synthesis in hypo and hyperthyroid rats. J. Exper. Med., 96: 513, 1952.
83.
Marx, W., Gustin, S.J., AND Levi, C.: Effects of thyroxine, thyroidectomy and lowered environmental temperature on incorporation of deuterium into cholesterol. Proc. Soc. Exper. Biol. & Med., 83: 143, 1953.
84.
Thompson, J.C. , AND Vars, H.M.: Influence of thyroid activity on the hepatic excretion of cholic acid and cholesterol. Am. J. Physiol. , 179: 405, 1954.
85.
Leroy, G.V. , Bergenstal, D.M., AND Kabora, J.J.: The rate of cholesterol synthesis in patients with myxedema. J. Lab. & Clin. Med., 44: 827, 1954.
86.
Eriksson, S. : Influence on thyroid activity on excretion of bile acids and cholesterol in the rat. Proc. Soc. Exper. Biol. & Med., 94: 582, 1957.
87.
Sjóvall, J.: Bile acids in man under normal and pathologic conditions. Clin. Chim. Acta5: 33, 1960.
88.
Tapley, D.F. , Daurdoff, F.F., Hatfield , W.B., AND Ross, J.E.: Physiological disposition of D- and L-thyroxine in the rat. Am. J. Physiol. , 197: 1021, 1959 .
89.
Tapley, D.F.: Distribution of thyroxine analogues in tissues. In Conference on Derivatives and Isomers of Thyroid Hormones, edited by M. L. Sachs. School of Medicine , University of Pennsylvania, 1960 .